このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Advanced Enzyme Technologies 過去の業績
過去 基準チェック /46
Advanced Enzyme Technologiesの収益は年間平均-1.3%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間16.4% 7.2%割合で 増加しています。 Advanced Enzyme Technologiesの自己資本利益率は10%であり、純利益率は21.4%です。
主要情報
-1.3%
収益成長率
-1.4%
EPS成長率
Chemicals 業界の成長 | 17.7% |
収益成長率 | 7.2% |
株主資本利益率 | 10.0% |
ネット・マージン | 21.4% |
前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)
Sep 21Does Advanced Enzyme Technologies (NSE:ADVENZYMES) Have A Healthy Balance Sheet?
Sep 08Have Insiders Sold Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Recently?
Aug 26Why We're Not Concerned About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Share Price
Aug 21Introducing Advanced Enzyme Technologies (NSE:ADVENZYMES), A Stock That Climbed 60% In The Last Year
Aug 20Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) P/E Is On The Mark
Aug 07Are Insiders Buying Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stock?
Jul 29How Does Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Fare As A Dividend Stock?
Jul 17Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Jul 04収支内訳
収支内訳
Advanced Enzyme Technologies の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
31 Mar 24 | 6,239 | 1,333 | 1,284 | 0 |
31 Dec 23 | 6,048 | 1,371 | 1,327 | 0 |
30 Sep 23 | 5,859 | 1,248 | 1,296 | 0 |
30 Jun 23 | 5,668 | 1,166 | 1,257 | 0 |
31 Mar 23 | 5,406 | 1,056 | 1,217 | 0 |
31 Dec 22 | 5,337 | 979 | 1,167 | 0 |
30 Sep 22 | 5,251 | 960 | 1,131 | 0 |
30 Jun 22 | 5,135 | 995 | 1,111 | 0 |
31 Mar 22 | 5,294 | 1,196 | 1,099 | 0 |
31 Dec 21 | 5,309 | 1,268 | 1,040 | 0 |
30 Sep 21 | 5,350 | 1,424 | 1,000 | 0 |
30 Jun 21 | 5,325 | 1,500 | 930 | 0 |
31 Mar 21 | 5,018 | 1,459 | 898 | 0 |
31 Dec 20 | 4,820 | 1,459 | 891 | 0 |
30 Sep 20 | 4,569 | 1,364 | 868 | 0 |
30 Jun 20 | 4,481 | 1,301 | 859 | 0 |
31 Mar 20 | 4,440 | 1,293 | 852 | 0 |
31 Dec 19 | 4,480 | 1,302 | 871 | 0 |
30 Sep 19 | 4,366 | 1,210 | 900 | 0 |
30 Jun 19 | 4,288 | 1,148 | 891 | 0 |
31 Mar 19 | 4,220 | 1,111 | 888 | 0 |
31 Dec 18 | 4,194 | 1,061 | 873 | 0 |
30 Sep 18 | 4,261 | 1,068 | 838 | 0 |
30 Jun 18 | 4,199 | 1,039 | 737 | 0 |
31 Mar 18 | 3,918 | 901 | 752 | 0 |
31 Dec 17 | 3,660 | 837 | 687 | 0 |
30 Sep 17 | 3,213 | 725 | 624 | 0 |
30 Jun 17 | 3,127 | 793 | 592 | 0 |
31 Mar 17 | 3,290 | 915 | 546 | 0 |
31 Dec 16 | 3,260 | 942 | 536 | 0 |
30 Sep 16 | 3,404 | 998 | 521 | 0 |
30 Jun 16 | 3,184 | 854 | 489 | 0 |
31 Mar 16 | 2,938 | 759 | 486 | 0 |
31 Mar 15 | 2,233 | 510 | 401 | 0 |
31 Mar 14 | 2,397 | 201 | 365 | 0 |
質の高い収益: ADVENZYMESは 高品質の収益 を持っています。
利益率の向上: ADVENZYMESの現在の純利益率 (21.4%)は、昨年(19.5%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: ADVENZYMESの収益は過去 5 年間で年間1.3%減少しました。
成長の加速: ADVENZYMESの過去 1 年間の収益成長率 ( 26.2% ) は、5 年間の平均 ( 年間-1.3%を上回っています。
収益対業界: ADVENZYMESの過去 1 年間の収益成長率 ( 26.2% ) はChemicals業界-0.4%を上回りました。
株主資本利益率
高いROE: ADVENZYMESの 自己資本利益率 ( 10% ) は 低い とみなされます。